Signet Investment Advisory Group, Inc. Amgen Inc Transaction History

Signet Investment Advisory Group, Inc.

$200 Million
Q3 2024

A detailed history of Signet Investment Advisory Group, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Signet Investment Advisory Group, Inc. holds 6,174 shares of AMGN stock, worth $1.63 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares

6,174

Previous 6,213 0.63%

Holding current value

$1.63 Million

Previous $1.94 Million 2.47%

% of portfolio

1.0%

Previous 1.04%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $12,065 - $13,157	-39 Reduced 0.63%	6,174 $1.99 Million
Q2 2024 Jul 19, 2024	BUY	$262.75 - $319.31 $25,224 - $30,653	96 Added 1.57%	6,213 $1.94 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $4,570 - $5,517	17 Added 0.28%	6,117 $1.74 Million
Q4 2023 Jan 25, 2024	SELL	$255.7 - $288.46 $4,346 - $4,903	-17 Reduced 0.28%	6,100 $1.76 Million
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $16,398 - $20,359	75 Added 1.24%	6,117 $1.64 Million
Q2 2023 Jul 19, 2023	BUY	$214.27 - $253.37 $26,140 - $30,911	122 Added 2.06%	6,042 $1.34 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $4,064 - $4,953	18 Added 0.3%	5,920 $1.43 Million
Q4 2022 Jan 20, 2023	SELL	$229.03 - $291.01 $9,619 - $12,222	-42 Reduced 0.71%	5,902 $0
Q3 2022 Oct 20, 2022	SELL	$224.46 - $253.15 $11,223 - $12,657	-50 Reduced 0.83%	5,944 $1.34 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $47,526 - $52,888	-206 Reduced 3.32%	5,994 $1.46 Million
Q1 2022 May 03, 2022	BUY	$219.27 - $242.57 $30,697 - $33,959	140 Added 2.31%	6,200 $1.5 Million
Q4 2021 Jan 27, 2022	BUY	$198.88 - $227.6 $17,899 - $20,484	90 Added 1.51%	6,060 $1.36 Million
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $38,208 - $44,766	180 Added 3.11%	5,970 $1.27 Million
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $64,701 - $71,781	-277 Reduced 4.57%	5,790 $1.41 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $73,674 - $85,855	-332 Reduced 5.19%	6,067 $1.51 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $133,722 - $159,240	-618 Reduced 8.81%	6,399 $1.47 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $2,270 - $2,918	12 Added 0.17%	7,017 $1.69 Million
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $9,576 - $11,474	-55 Reduced 0.78%	7,005 $1.36 Million
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $41,675 - $48,852	-250 Reduced 3.42%	7,060 $1.3 Million
Q1 2019 May 06, 2019	BUY	$180.87 - $203.88 $9,947 - $11,213	55 Added 0.76%	7,310 $1.39 Million
Q4 2018 Jan 31, 2019	BUY	$178.4 - $208.25 $1.29 Million - $1.51 Million	7,255 New	7,255 $1.41 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signet Investment Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Signet Investment Advisory Group, Inc. with notifications on news.

Account

Signet Investment Advisory Group, Inc. Amgen Inc Transaction History